naphthalimides has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, J; Gao, J | 1 |
| Chapman, JM; Gao, J; McInnes, C; Midde, N; Terry, AV; Zhu, J | 1 |
2 other study(ies) available for naphthalimides and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Discovery and Characterization of Novel Naphthalimide Analogs as Potent Multitargeted Directed Ligands against Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cholinesterase Inhibitors; Humans; Ligands; Naphthalimides | 2023 |
Synthesis and biological evaluation of ranitidine analogs as multiple-target-directed cognitive enhancers for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Mice; Models, Molecular; Naphthalimides; Nootropic Agents; Ranitidine; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Structure-Activity Relationship | 2016 |